↓ Skip to main content

Dove Medical Press

Article Metrics

Natalizumab in the treatment of multiple sclerosis

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

patent
5 patents

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
18 Mendeley
Title
Natalizumab in the treatment of multiple sclerosis
Published in
Therapeutics and Clinical Risk Management, July 2009
DOI 10.2147/tcrm.s5218
Pubmed ID
Authors

Brandon Brown

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 6%
Brazil 1 6%
Unknown 16 89%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 28%
Student > Ph. D. Student 2 11%
Student > Master 2 11%
Student > Bachelor 1 6%
Other 1 6%
Other 1 6%
Unknown 6 33%
Readers by discipline Count As %
Medicine and Dentistry 6 33%
Biochemistry, Genetics and Molecular Biology 3 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Economics, Econometrics and Finance 1 6%
Agricultural and Biological Sciences 1 6%
Other 0 0%
Unknown 6 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2019.
All research outputs
#2,323,933
of 16,793,177 outputs
Outputs from Therapeutics and Clinical Risk Management
#105
of 1,090 outputs
Outputs of similar age
#59,705
of 284,431 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#4
of 29 outputs
Altmetric has tracked 16,793,177 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,090 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 284,431 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.